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ABSTRACT
Objective: To estimate the prevalence of wounds
managed by the UK’s National Health Service (NHS) in
2012/2013 and the annual levels of healthcare resource
use attributable to their management and
corresponding costs.
Methods: This was a retrospective cohort analysis of
the records of patients in The Health Improvement
Network (THIN) Database. Records of 1000 adult
patients who had a wound in 2012/2013 (cases) were
randomly selected and matched with 1000 patients
with no history of a wound (controls). Patients’
characteristics, wound-related health outcomes and all
healthcare resource use were quantified and the total
NHS cost of patient management was estimated at
2013/2014 prices.
Results: Patients’ mean age was 69.0 years and 45%
were male. 76% of patients presented with a new
wound in the study year and 61% of wounds healed
during the study year. Nutritional deficiency (OR 0.53;
p<0.001) and diabetes (OR 0.65; p<0.001) were
independent risk factors for non-healing. There were an
estimated 2.2 million wounds managed by the NHS in
2012/2013. Annual levels of resource use attributable
to managing these wounds and associated
comorbidities included 18.6 million practice nurse
visits, 10.9 million community nurse visits, 7.7 million
GP visits and 3.4 million hospital outpatient visits. The
annual NHS cost of managing these wounds and
associated comorbidities was £5.3 billion. This was
reduced to between £5.1 and £4.5 billion after
adjusting for comorbidities.
Conclusions: Real world evidence highlights wound
management is predominantly a nurse-led discipline.
Approximately 30% of wounds lacked a differential
diagnosis, indicative of practical difficulties experienced
by non-specialist clinicians. Wounds impose a
substantial health economic burden on the UK’s NHS,
comparable to that of managing obesity (£5.0 billion).
Clinical and economic benefits could accrue from
improved systems of care and an increased awareness of
the impact that wounds impose on patients and the NHS.
INTRODUCTION
Patients requiring wound care can be found
in the community, secondary care and in
long-term care institutions and range from
infants to the elderly. The patient population
with wounds is managed across the spectrum
of different healthcare disciplines that
includes general practice, specialist physi-
cians, surgeons, nurses and allied healthcare
practitioners, such as podiatrists.1–3
Wound care should be viewed as a specia-
lised segment of healthcare that requires
clinicians with specialist training to diagnose
and manage appropriately.4 5 However, the
evidence suggests this is not the case.1–3
Moreover, it has been suggested that better
wound care, such as effective diagnosis and
treatment and effective prevention of wound
Strengths and limitations of this study
▪ This study estimated the health outcomes,
resource implications and associated costs
attributable to managing wounds in 2012/2013
using real world evidence obtained from The
Health Improvement Network (THIN) database (a
nationally representative database of clinical
practice among >11 million patients registered
with general practitioners in the UK).
▪ The estimates were derived following a system-
atic analysis of patients’ characteristics,
wound-related health outcomes and all
community-based and secondary care resource
use contained in the patients’ electronic records.
▪ Computerised information in the THIN database
is collected by general practitioners (GPs) for
clinical care purposes and not for research.
Additionally, prescriptions issued by GPs and
practice nurses are recorded in the database, but
it does not specify whether the prescriptions
were dispensed or patient compliance with the
product.
▪ The analysis does not consider the potential
impact of those wounds that remained unhealed
beyond the study period. Nor does it consider
the potential impact of managing patients with
wounds being cared for in nursing homes. The
THIN database may have under-recorded use of
some healthcare resources outside the GP’s
surgery. However, the impact of this was
addressed in sensitivity analyses.
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complications would help minimise treatment costs.
Studies have highlighted that there is potential for
better patient management and wound care product
selection that would improve outcomes and reduce
costs.1–3 6 7
There have been previous attempts to estimate the
costs and burden associated with wound management in
the UK. However, they were based on published litera-
ture or broad estimates derived from incidence or preva-
lence rates and extrapolations from relatively small-scale
studies. The objectives of the present study were to esti-
mate: the annual prevalence of wounds and annual
number of wounds that are treated by the UK’s publicly-
funded National Health Service (NHS); the annual
amount of NHS resource use that is utilised on wound
management; and the amount the NHS spends on man-
aging wounds in 2012/2013. The remit of this study was
limited to open external acute and chronic cutaneous
wounds. Surgical wounds healing within 4 weeks were
excluded as costs were considered to be related to the
surgery and not to ongoing wound complications.
METHODS
Study design
This was a retrospective cohort analysis of the records of
patients in The Health Improvement Network (THIN)
database.
The THIN database
The THIN database (Cegedim, London, UK) contains
computerised information on >11 million anonymised
patients entered by general practitioners (GPs) from 562
practices across the UK. General practices across the UK
using Vision Practice Management Software are invited
to participate in the database and are self-selecting. The
patient data within THIN have been shown to be repre-
sentative of the UK population in terms of demograph-
ics and disease distribution.8 Read codes are a coded
thesaurus of clinical terms that have been in use in the
NHS since 1985,9 and have been used to code speciﬁc
diagnoses in the THIN database. A drug dictionary
based on data from the Multilex classiﬁcation has been
used to code drugs in the database. Successive updates
of patients’ records to the database include any subse-
quent changes made by GPs.
The computerised information in the THIN database
includes patients’ demographics, details from GP consul-
tations, specialist referrals, nurse and other clinician
visits, hospital admissions, diagnostic and therapeutic
procedures, laboratory tests and prescriptions issued in
primary care that are directly generated by the general
practice’s information technology system. Hence, the
information contained in the THIN database reﬂects
real clinical practice, as it is based on actual patient
records. Moreover, GPs are the gatekeepers to health-
care in the UK, and patients’ entire medical history
should be stored in their primary care record.
Study population
The study population comprised the anonymised case
records of a randomly selected cohort of 1000 patients
from the THIN database who had a wound between 1
May 2012 and 30 April 2013 (cases) and a randomly
selected cohort of 1000 control patients (controls) from
the database, who were matched with the cases accord-
ing to age, gender and the patient’s general practice.
Inclusion criteria for the cases were:
▸ Had to be aged 18 years or above.
▸ Had to have a Read code for a wound.
▸ Had to have continuous medical history in their case
record from the ﬁrst mention of a wound in the
study year up to the time the data were extracted
from the database, unless they died, in order to
exclude patients who had moved or changed their
general practice.
Exclusion criteria for the cases were:
▸ Patients with a surgical wound if they healed within
4 weeks of the surgical procedure (since any resource
use incurred will be due to the surgical procedure
and not the wound).
▸ Patients with a dermatological tumour.
1000 control patients were matched with 1000 cases
according to the following criteria:
▸ Age.
▸ Gender.
▸ Being managed at the same general practice.
▸ No history of a wound in their medical record at
anytime.
▸ Had continuous medical history in their case record
from the matched start date up to the time the data
were extracted from the database unless they died.
The authors obtained the complete medical records
of the 2000 patients in the data set, which enabled ana-
lysis of data within and outside of the study period.
Ethics approval
Ethics approval to use the complete patients’ records
from the THIN database for this study was obtained
from Cegedim’s Research Ethics Committee that
appraises studies using the THIN database (Reference
number 13–061).
Study variables and statistical analyses
Information was systematically extracted from the
patients’ records over the study period according to the
protocol approved by the ethics committee. Wound type
was documented in the patients’ records and the
authors categorised them as being either acute (ie,
abscess, burn, open wound, unhealed surgical wound,
trauma) or chronic (ie, diabetic foot ulcer, arterial leg
ulcer, mixed leg ulcer, venous leg ulcer, pressure ulcer).
Patients’ characteristics, comorbidities (deﬁned as a
non-acute condition that patients were suffering from in
the year before the start of their wound and not neces-
sarily the year before the start of the study),
wound-related health outcomes and all community-
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based and secondary care resource use were extracted
from the electronic records. All the data were quantiﬁed
for cases and controls and stratiﬁed according to wound
type. Differences between the groups were tested for
statistical signiﬁcance using either a Mann-Whitney
U-test or a χ2 test.
Logistic regression was used to investigate relationships
between baseline variables and clinical outcomes.
Multiple linear regression was also used to assess the
impact of patients’ baseline variables on resource use and
clinical outcomes. All statistical analyses were performed
using IBM SPSS Statistics (V.22.0; IBM Corporation).
Health economic modeling
Using the THIN data set, a computer-based model was
constructed depicting the treatment pathways and asso-
ciated management of the 1000 patients with a wound
and the 1000 matched patients who had never had a
wound. The model spans the 12 months period from 1
May 2012 to 30 April 2013.
Unit costs at 2013/2014 prices10–12 were applied to the
resource use in the model to estimate the total NHS cost of
patient management from the time a patient entered the
data set (ie, from 1 May 2012 or the start time of their
wound if it occurred later, and the equivalent date in the
matched control) up to the time their wound healed or
the end of the study period, whichever came ﬁrst.
Differences between cases and controls were considered to
be attributable to wound care and associated comorbidities.
Sensitivity analyses
Deterministic sensitivity analyses were performed on all
of the model’s inputs to identify how the cost of wound
management and associated comorbidities would change
by varying the different parameters in the model.
Two methods were used to adjust for the cost of man-
aging patients’ comorbidities.
1. The ﬁrst involved generating an incremental cost
among control patients between those who had no
comorbidities and those who had one, two, three,
four or ﬁve or more comorbidities. These incremen-
tal costs were then applied to both groups so that all
the patients were modelled to have the maximum
number of comorbidities. The resulting cost differ-
ence between the two groups was considered to be
solely due to the wounds.
2. The second method involved the removal of a case–
control match from the analysis if they did not have
the same number of comorbidities. The resulting
cost difference between the two groups was consid-
ered to be solely due to the wounds.
RESULTS
Patients’ characteristics
Patients’ mean age in the cases and controls was 69.0
and 67.3 years, respectively, and 55% of patients in both
groups were female. Mean blood pressure was 133/76 in
the cases and 132/77 in the controls. Additionally,
patients’ body mass index was a mean 29.0 kg/m2 and
26.1 kg/m2 in the cases and controls respectively. 18%
of the cases were smokers, 39% were non-smokers and
40% were ex-smokers. In the controls, 17% were
smokers, 47% were non-smokers and 32% were
ex-smokers. Seventy six per cent of cases presented with
a new wound in the study year (patients’ records
predated the onset of the study period, enabling both
pre-existing and new wounds to be identiﬁed. A similar
process allowed wound healing to be characterised).
There was no evidence that patients in the data set had
more than one wound. However, 72% of patients had a
wound a mean 4.9 years prior to the one being evalu-
ated in the study period.
Signiﬁcantly more patients with a wound (94%) than
control patients (77%) had at least one comorbidity in
the year before the start of their wound. Moreover, the
mean number of comorbid conditions in the cases was
3.9 per patient compared to 2.1 per patient in the con-
trols. The percentage of patients with different
comorbidities in the year before the start of their wound
(and not necessarily the year before the start of the
study) is summarised in table 1.
Binary logistic regression was performed on patients’
age, gender, smoking status and all comorbidities. Those
variables that yielded a p value ≥0.05 were omitted from
the analysis resulting in the following comorbidities
being considered as independent risk factors for develo-
ping a wound:
▸ Dermatological symptoms: OR 3.26 (95% CI 2.66 to
4.00); p<0.001.
▸ Nutritional deﬁciency: OR 2.30 (95% CI 1.80 to
2.95); p<0.001.
▸ Musculoskeletal disease: OR 1.62 (95% CI 1.29 to
2.03); p<0.001.
Table 1 Percentage of patients with a comorbidity in the
year before the start of their wound
Percentage of patients
p ValueComorbidity
Cases
(%)
Controls
(%)
Cardiovascular 73 53 <0.005
Dermatological 59 25 <0.001
Endocrinological 45 27 <0.01
Gastroenterological 43 25 <0.01
Immunological 3 0 ns
Musculoskeletal 37 19 <0.005
Neurological 23 13 ns
Nutritional
deficiency
34 13 <0.001
Other 14 7 ns
Psychiatric 31 18 <0.05
Respiratory 28 15 ns
None 6 23 <0.001
If the p value was ≥0.05 it was considered not significant (ns).
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▸ Cardiovascular disease: OR 1.35 (95% CI 1.09 to
1.67); p=0.005.
▸ Gastrointestinal disease: OR 1.32 (95% CI 1.06 to
1.64); p=0.015.
Prevalence of wounds in the UK
The base population of active patients in the THIN data-
base in 2012/2013 was 3.9 million, from which there
were an estimated 135 000 patients with a wound that
matched the study protocol’s inclusion and exclusion
criteria. When this was extrapolated to the whole UK
population (63.7 million people in mid-2013), it was esti-
mated that there were 2.2 million patients with a wound
who matched the study protocol’s inclusion and exclu-
sion criteria, equivalent to 4.5% of the adult population,
in the study year (table 2).
Twelve per cent of all wounds had no diagnosis and it
was not possible to infer a wound type from the patients’
records. Additionally, 19% of all wounds were a leg ulcer
without any further characterisation (ie, venous, arterial or
mixed). In total, there were 730 000 leg ulcers, which
equates to 1.5% of the adult population having a leg ulcer
in the study year. The number of diagnosed venous leg
ulcers (278 000) indicates that 1 in 170 adults had such an
ulcer in the study year. There were also an estimated
169 000 diabetic foot ulcers, which equates to 5% of adult
diabetic patients having a foot ulcer in the study year, of
which 66% were male. There was no evidence that any of
the patients in our data set had more than one wound.
Clinical outcomes
Sixty one per cent of all wounds healed in the study
year; 79% of acute wounds healed and 43% of chronic
wounds. Binary logistic regression suggests that nutri-
tional deﬁciency (OR 0.53 (95% CI 0.41 to 0.70);
p<0.001) and diabetes (OR 0.65 (95% CI 0.50 to 0.85);
p<0.001) were independent risk factors for non-healing
during the study period. Additionally, 4% of patients
with a wound and 1% of control patients died in the
study year.
Healthcare resource use associated with patient
management
Patients in both groups were predominantly managed in
the community by GPs and nurses. Table 3 summarises
the percentage of patients in each group who utilised
different resources during the study year.
Table 4 shows the annual number of resources asso-
ciated with managing 2.2 million patients with a wound
and 2.2 million control patients. The differences were
considered to be the incremental amounts of resource
use attributable to managing 2.2 million wounds and
associated comorbidities and included 18.6 million prac-
tice nurse visits, 10.9 million community nurse visits, 7.7
million GP visits, 3.4 million hospital outpatient visits,
97.1 million drug prescriptions, 262.2 million dressings,
73.4 million bandages and 9.0 million compression ban-
dages. Assessment of peripheral perfusion is a recog-
nised requirement for leg ulcer and diabetic foot
management, yet only 16% of all cases with a leg or foot
ulcer had a Doppler ankle brachial pressure index
recorded in their records.
The total annual NHS cost of managing 2.2 million
patients with a wound was estimated to be £6.0 billion
(table 5). The corresponding cost of managing the
matched controls was £0.7 billion. Hence, the total
annual NHS cost of managing 2.2 million wounds and
associated comorbidities was estimated to be £5.3 billion.
Of this, £2.1 billion and £3.2 billion was associated with
managing those wounds that healed and remained
unhealed respectively.
Sixty six per cent of the total annual NHS cost was
incurred in the community and the remainder in sec-
ondary care. However, the distribution of costs varied
according to wound type, with 48% and 78% of the total
annual NHS cost of managing acute and chronic
wounds, respectively, being incurred in the community
and the remainder in secondary care.
Sensitivity analyses
The estimated amounts of individual resource use were
reduced and increased by 25%. However, this only affected
the total annual NHS cost of managing 2.2 million
wounds and associated comorbidities by 6% or less.
The cost of an initial surgical procedure may not be
relevant to the cost incurred in managing an unhealed
surgical wound. Therefore, a sensitivity analysis was per-
formed to exclude this cost from the cost of managing
patients with an unhealed surgical wound. The analysis
found that when the cost of surgery was excluded from
the cost of managing patients with an unhealed surgical
Table 2 Annual number and prevalence of different
wound types in the UK
Annual number
of wounds
Annual
prevalence
among the adult
UK population
Abscess 160 000 (7%) 0.0032
Burn 87 000 (4%) 0.0018
Diabetic foot ulcer 169 000 (8%) 0.0034
Leg ulcer (arterial) 9000 (<1%) 0.0002
Leg ulcer (mixed) 24 000 (1%) 0.0005
Leg ulcer
(unspecified)
420 000 (19%) 0.0085
Leg ulcer (venous) 278 000 (13%) 0.0056
Open wound 240 000 (11%) 0.0048
Pressure ulcer 153 000 (7%) 0.0031
Surgical wound 253 000 (11%) 0.0051
Trauma 158 000 (7%) 0.0032
Unspecified 271 000 (12%) 0.0055
Total 2 222 000 (100%) 0.0447
Among the adult population (ie, ≥18 years of age) estimated from
the THIN database.
THIN, The Health Improvement Network.
Percentage of total number of wounds is in parentheses.
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wound, the total annual NHS cost of managing 2.2
million wounds and associated comorbidities was
reduced from £5.3 billion to £4.8 billion.
When the NHS cost of managing patients was adjusted
for their comorbidities (see description of method 1 and
2 sections under Sensitivity analyses), the total annual
NHS cost of managing 2.2 million wounds was reduced
from £5.3 billion to £5.1 billion when method 1 was used
and to £4.5 billion when method 2 was used. Hence, the
total annual NHS cost of managing the comorbidities
among 2.2 million patients with a wound was estimated
to be between £250 and £788 million. After adjusting for
comorbidities, the total annual NHS cost of managing
healed wounds and unhealed wounds was estimated to
be £2.0 billion and £3.0 billion, respectively.
DISCUSSION
This study estimated the health outcomes, resource
implications and associated costs attributable to
managing wounds in 2012/2013. After adjustment for
comorbidities, the annual NHS cost of managing
wounds was estimated to be £4.5–5.1 billion, two-thirds
of which is incurred in the community and the rest in
secondary care. This is comparable to the annual NHS
cost of managing obesity which was estimated at £5.0
billion in 2013.13
For patients to be included in the data set, they had to
have had a wound in the study year or be matched to
these patients on the basis of their age, sex, the same
general practice, and no evidence of a wound in their
medical history. Patients in both groups were managed
primarily by clinicians in the community. Only half the
patients with a wound saw a hospital physician although
the consultation may not have been wound-related.
However, the evidence shows that wound management is
predominantly a nurse-led discipline. Approximately
30% of wounds lacked a differential diagnosis. This may
be indicative of the practical difﬁculties experienced by
non-specialist healthcare professionals in the community
Table 3 Percentage of patients who utilised resources in the study year
Percentage of patients
p ValueResource Cases (%) Controls (%)
GP visits 86 47 <0.001
Practice nurse visits 72 29 <0.001
Community nurse visits 75 2 <0.001
Specialist nurse visits 2 <1 ns
Allied healthcare visits 14 3 0.005
Hospital outpatient visits 53 18 <0.001
Hospital admissions and day cases 29 6 <0.001
Ambulance services <1 <1 ns
Accident and emergency attendances <1 <1 ns
Diagnostic tests 80 45 <0.001
Non-wound care devices 36 5 <0.001
Wound care products 100 0 <0.001
Prescriptions for individual drugs 98 72 <0.001
GP, general practitioner.
Table 4 Annual amount of NHS resource use attributable to managing 2.2 million patients with a wound and 2.2 million
matched controls
Annual number
p ValueResource Cases Controls Difference
GP visits 10 816 655 3 124 120 7 692 535 <0.001
Practice nurse visits 19 744 618 1 184 322 18 560 296 <0.001
Community nurse visits 10 932 199 75 548 10 856 651 <0.001
Specialist nurse visits 51 106 4444 46 662 <0.001
Allied healthcare visits 537 722 77 770 459 952 <0.001
Hospital outpatient visits 4 277 334 828 803 3 448 531 <0.001
Hospital admissions and day cases 1 142 104 173 315 968 788 <0.001
Ambulance services 11 110 2222 8888 ns
Accident and emergency attendances 11 110 11 110 – ns
Diagnostic tests 60 284 855 24 068 613 36 216 242 <0.001
Devices 320 938 916 48 206 108 272 732 808 <0.001
Wound care products 354 954 275 0 354 954 275 <0.001
Prescriptions for individual drugs 135 859 234 38 769 310 97 089 924 <0.001
GP, general practitioner; NHS, National Health Service.
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with establishing a working diagnosis. Moreover, it
appears that only 16% of patients with a leg or foot
ulcer had a Doppler. However, national guidance in the
UK for both leg ulcer management and the manage-
ment of diabetic foot ulceration requires arterial assess-
ment by Doppler ultrasound measurement of the
ankle-brachial pressure index.14 15 Hence, these ﬁndings
suggest (1) the need to refer patients to a specialist for
investigation and a differential diagnosis and a shared
management plan to be implemented in the community
and (2) training of non-specialist clinicians in the funda-
mentals of wound management. These two measures
should help overcome some of the problems encoun-
tered in clinical practice and achieve better health out-
comes, thereby reducing the high levels of resource use
and corresponding costs, and improving compliance
with appropriate National Institute for Health and
Care Excellence (NICE) and best practice guidelines.
The study highlighted that despite being a nurse-led
discipline, there is a lack of involvement of tissue viabil-
ity nurses and other specialist nurses in the management
of patients with wounds. Recent articles16 17 highlight
the lack of a clear deﬁnition, and therefore confusion
regarding the role of these nurses.
The wound patients had signiﬁcantly more comorbid-
ities than their matched controls. However, it was surpris-
ing to ﬁnd such a high level of illness among the
controls. For example, 53% had cardiovascular disease.
Moreover, 34% of patients with a wound and 13% of
controls had nutritional deﬁciency that warranted sup-
plementation with clinical nutritional formulae. The
THIN data set in this study covers the period 2012/2013
and comprises patients with a wide age range
(19–98 years), so this level of illness may be a proxy for
the health of a proportion of the general population at
that time. Furthermore, the presence of nutritional
deﬁciency was an independent risk factor for wound
non-healing. Hence, community-prevention of patients
developing nutritional deﬁciency should help improve
healing rates following the onset of a wound. Moreover,
if patients’ wounds and their comorbidities were treated
more holistically with appropriate involvement of allied
healthcare professionals, rather than just focusing on
the wounds, better health outcomes might be achieved
at lower cost.
Other studies have assessed the prevalence and costs
of wound care. A district-wide survey in the Bradford
and Airedale area of the UK estimated the annual NHS
cost of wound care to be £2.0 million/100 000 popula-
tion,18 which equates to £1.3 billion for the UK as a
whole. In another study, the NHS cost of caring for
patients with a chronic wound was estimated to be £2.3–
3.1 billion per year at 2005/2006 prices.19 Previous
prevalence studies suggest there may be up to 190 000
individuals with a venous leg ulcer in the UK at any
time.19 However, this is likely to be an underestimate as
our analysis estimated that the NHS manages 278 000
venous leg ulcers per annum plus an additional 420 000
unspeciﬁed leg ulcers (ie, those lacking a true working
diagnosis), some of which will undoubtedly be venous in
origin. The prevalence of pressure ulcers has been previ-
ously estimated to be 0.103 in 2005/200620 and another
study estimated the incidence to be 400 000 new pres-
sure ulcers per annum in the UK.19 These ﬁgures are
substantially higher than our estimate of the NHS man-
aging 153 000 pressure ulcers per annum. The differ-
ence may be due to people residing in nursing homes
not having been included in our study. It may also be
due to under-recording of pressure ulcers in patients’
records and/or an over-estimation in the previous
studies, and/or a lower prevalence in 2012/2013 than in
2005/2006. The present study also estimated that 5% of
patients with diabetes have a foot ulcer which is consist-
ent with other estimates.21
Table 5 Annual cost of NHS resource use attributable to managing 2.2 million patients with a wound and 2.2 million
matched controls
Annual cost
Resource Cases Controls Difference
GP visits £514 993 223 £145 951 520 £369 041 702
Practice nurse visits £256 760 021 £15 396 180 £241 363 841
Community nurse visits £682 382 518 £3 026 353 £679 356 166
Specialist nurse visits £3 650 732 £322 189 £3 328 543
Allied healthcare visits £34 451 980 £4 859 496 £29 592 485
Hospital outpatient visits £515 002 111 £99 947 406 £415 054 705
Hospital admissions and day cases £1 334 299 309 £135 277 073 £1 199 022 237
Ambulance services £2 555 290 £511 058 £2 044 232
Accident and emergency attendances £666 597 £666 597 £0
Diagnostic tests £282 646 224 £113 238 466 £169 407 758
Devices £282 261 975 £17 525 292 £264 736 682
Wound care products £742 703 819 £0 £742 703 819
Prescriptions for individual drugs £1390 246 214 £188 175 050 £1 202 071 164
TOTAL £6 042 620 014 £724 896 679 £5 317 723 335
GP, general practitioner; NHS, National Health Service.
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The advantage of using the THIN database is that
the patient pathways and associated resource use are
based on real world evidence derived from clinical
practice. However, health outcomes and resource use,
while collected prospectively, were analysed retrospect-
ively. Moreover, there was no intention to match
patients for comorbidities, since differences in
comorbidities between the groups were an intended
outcome of the study. Sensitivity analyses estimated that
the cost of managing the comorbidities ranged
between £250 and £788 million. Nevertheless, the possi-
bility of resource use associated with managing a
comorbidity being conﬂated with that of wound man-
agement cannot be excluded. Hence, confounding
factors may exist. While the study results are compel-
ling, the analyses were based on clinicians’ entries into
their patients’ records and inevitably subject to a
certain amount of imprecision and lack of detail.
Moreover, the computerised information in the THIN
database is collected by GPs for clinical care purposes
and not for research. Prescriptions issued by GPs and
practice nurses are recorded in the database, but it
does not specify whether the prescriptions were dis-
pensed or patient compliance with the product.
Despite these limitations, it is the authors’ opinion that
the THIN database affords one of the best sources of
real world evidence for clinical practice in the UK.
The analysis does not consider the potential impact of
those wounds that remained unhealed beyond the study
period, nor does it consider the potential impact of
managing patients with wounds being cared for in
nursing/residential homes. The THIN database may
have under-recorded use of some healthcare resources
outside the GP’s surgery if not documented in the GP
records, such as home visits made by clinicians, hospital
outpatient visits, hospital admissions and accident and
emergency attendances. The impact of this was
addressed in sensitivity analyses. The analysis excludes
hospital-based prescribing, but this should have minimal
impact on the results since most prescribing is under-
taken by GPs and nurses in the community.
The analysis only considered the annual cost of NHS
resource use for the ‘average patient,’ and no attempt
was made to stratify resource use and costs according to
gender, comorbidities, wound size, wound severity and
other disease-related factors. Also excluded were the
costs incurred by patients and indirect costs incurred by
society as a result of patients taking time off work.
However, patients’ mean age was >65 years, so it is
unlikely that many were in employment.
Notwithstanding the study’s limitations, the real
world evidence in our study demonstrates that wounds
impose a substantial health economic burden on the
UK’s NHS, comparable to that of managing obesity.
Clinical and economic beneﬁts could accrue from
improved systems of care and an increased awareness
of the impact that wounds impose on patients and the
NHS.
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